Clarification10 Jun 2026, 02:50 pm
Solara Active Pharma Clarifies Volume Movement to BSE
AI Summary
Solara Active Pharma Sciences Ltd has responded to an email from the BSE dated June 10, 2026, regarding a significant increase in trading volume for its securities. The company clarified that it has complied with all disclosure requirements under SEBI regulations and has not withheld any material information that could impact the stock's price or volume behavior. This statement aims to assure the exchange and investors of the company's transparency and adherence to listing norms.
Key Highlights
- Company addressed BSE's query on significant volume movement.
- Confirmed compliance with SEBI disclosure regulations.
- Stated no material information was withheld.
- Reassured investors about transparency and adherence to norms.
Price Impact
More from SOLARA